Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

BD unveils plan for €165 million Spanish manufacturing plant

May 19, 2021 Research and Development EU, manufacturing

BD has announced plans to build a new €160 million manufacturing plant in Zaragoza, located in the Aragon region of …
News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

May 12, 2021 Research and Development COVID-19

The past week has seen India’s highest number of COVID-19 deaths, with 4,205 fatalities in a single day. There has …
News

India report record number of COVID deaths as bodies drift down Ganges

May 12, 2021 Research and Development COVID-19, India, Indian COVID crisis, covid 19 news, covid-19 news, pharma, pharma news

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.
News
MHRA sign

Astellas prostate cancer drug gets third approval from MHRA

May 12, 2021 Research and Development Astellas, MHRA, cancer research, cancer treatment, pharma, pharma news, prostate cancer

The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making …
News

NICE rejects Pfizer’s Vyndaqel for treating rare heart condition

May 12, 2021 Research and Development NICE, Pfizer, Vyandaqel

NICE has published final guidance today which rejects tafamidis, also known as Vyndaqel, for treating rare heart condition transthyretin amyloidosis …
News

Endogena’s retinitis pigmentosa treatment granted Orphan Drug Designation by FDA

May 12, 2021 Research and Development DFA, Endogena, Orphan Drug Designation

Endogena Therapeutics Inc has been granted Orphan Drug Designation for its EA-2353 ophthalmic suspension targeting retinitis pigmentosa by the FDA. …
News

Eli Lilly and MiNA Therapeutics to collaborate on saRNA research

May 12, 2021 Research and Development Eli Lilly

Eli Lilly and MiNA Therapeutics have announced a global research collaboration to develop novel drug candidates using MiNA’s proprietary small …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

May 5, 2021 Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen more COVID-19 vaccine and treatment news: Moderna will supply up to 500 million jabs to …
News

Theramex releases Vitamin D gel aimed at women

May 5, 2021 Research and Development Theramex, osteoporosis, pharma, pharma news, vitamin d

Theramex has launched a new gel for Vitamin D deficiency, in the hope that it will particularly treat women experiencing …
News

UK government to invest £29.3 million on COVID-19 variant testing

May 5, 2021 Research and Development COVID-19, UK government, Vaccine, variants

The UK government has announced an investment of £29.3 million, on top of the £19.7 million already pledged, to be …
News
janssen_latest_logo_on_sign

Janssen submits MAA to EMA for novel CAR-T cell therapy

May 5, 2021 Research and Development EMA, EU, Janssen, multiple myeloma

Janssen have submitted a Marketing Authorisation Application (MAA) to the EMA seeking approval of cilta-cel, an investigational B cell maturation …
News

New HIV prevention drug application submitted to FDA

May 5, 2021 Research and Development FDA, HIV

ViiV Healthcare have initiated a rolling submission of a new drug application (NDA) with the FDA for their long-acting HIV …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 28, 2021 Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …
News

COVID Symptom Study app reveals most common vaccine side effects

April 28, 2021 Research and Development COVID-19, Vaccine, data

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
News

Calliditas’ kidney disease drug granted priority review by FDA

April 28, 2021 Research and Development Calliditas, FDA, nephropathy, pharma, pharma news

The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025